AbbVie to Settle More Than 4,000 Testosterone-Drug Lawsuits (1)

AbbVie Inc. agreed to resolve more than 4,000 lawsuits in which it was accused of hiding the health risks of its AndroGel testosterone booster and illegally marketing the drug to men seeking to enhance their sex lives.

The decision comes after seven trials over AbbVie’s marketing of AndroGel. A federal jury in Chicago awarded Jesse Mitchell $150 million in damages, but a judge ordered a new trial. Mitchell was awarded $3.2 million following the retrial, which AbbVie appealed. In a second test trial, a jury awarded $140 million in damages to the victim, but a judge overturned that verdict as ...